Literature DB >> 21172095

The epidemiology of excess mortality in people with mental illness.

David Lawrence1, Stephen Kisely, Joanne Pais.   

Abstract

OBJECTIVE: to investigate the burden of excess mortality among people with mental illness in developed countries, how it is distributed, and whether it has changed over time.
METHOD: we conducted a systematic search of MEDLINE, restricting our attention to peer-reviewed studies and reviews published in English relating to mortality and mental illness. Because of the large number of studies that have been undertaken during the last 30 years, we have selected a representative cross-section of studies for inclusion in our review.
RESULTS: there is substantial excess mortality in people with mental illness for almost all psychiatric disorders and all main causes of death. Consistently elevated rates have been observed across settings and over time. The highest numbers of excess deaths are due to cardiovascular and respiratory diseases. With life expectancy increasing in the general population, the disparity in mortality outcomes for people with mental illness is increasing.
CONCLUSIONS: without the development of alternative approaches to promoting and treating the physical health of people with mental illness, it is possible that the disparity in mortality outcomes will persist.

Entities:  

Mesh:

Year:  2010        PMID: 21172095     DOI: 10.1177/070674371005501202

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  65 in total

1.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Regional tertiary psychiatric care and rehabilitation authorities for people with severe mental illness in Canada.

Authors:  Alain Lesage
Journal:  Can J Psychiatry       Date:  2014-04       Impact factor: 4.356

3.  Trend in rates for deaths with mention of schizophrenia on death certificates of US residents, 1999-2010.

Authors:  Anthony P Polednak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-23       Impact factor: 4.328

4.  Excess mortality in people with mental illness: findings from a Northern Italy psychiatric case register.

Authors:  Fabrizio Starace; Francesco Mungai; Flavia Baccari; Gian Maria Galeazzi
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-12-22       Impact factor: 4.328

5.  Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.

Authors:  Joelle C Ferron; Timothy Devitt; Gregory J McHugo; Jessica A Jonikas; Judith A Cook; Mary F Brunette
Journal:  Community Ment Health J       Date:  2016-03-01

Review 6.  Management of schizophrenia in late life with antipsychotic medications: a qualitative review.

Authors:  Takefumi Suzuki; Gary Remington; Hiroyuki Uchida; Tarek K Rajji; Ariel Graff-Guerrero; David C Mamo
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

7.  Mental illness and use of screening mammography among Medicaid beneficiaries.

Authors:  Siran M Koroukian; Paul M Bakaki; Negar Golchin; Carl Tyler; Sana Loue
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

8.  Performance in Practice: Practice Assessment Tool for the Care of Patients With Schizophrenia.

Authors:  Laura J Fochtmann; Jennifer Medicus; Seung-Hee Hong
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

9.  Temporal associations between physical illnesses and mental disorders--results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  S Patricia Chou; Boji Huang; Risë Goldstein; Bridget F Grant
Journal:  Compr Psychiatry       Date:  2013-03-20       Impact factor: 3.735

10.  Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications.

Authors:  Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.